Prostatype Genomics AB (publ) at its annual general meeting held on 23 May 2024, Johan Waldhe was elected as new member of the board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.026 SEK | 0.00% |
|
-38.20% | -71.05% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-71.05% | 2.47M | |
-16.71% | 8.53B | |
+67.76% | 4.31B | |
+4.98% | 2.67B | |
-2.63% | 2.62B | |
-53.41% | 1.87B | |
-19.59% | 1.66B | |
-21.62% | 1.41B | |
+16.16% | 1.2B | |
-46.45% | 1.09B |
- Stock Market
- Equities
- PROGEN Stock
- News Prostatype Genomics AB
- Prostatype Genomics AB Elects Johan Waldhe as New Member of the Board